91麻豆精品国产综合久久久,人人玩人人添人人澡超碰,五月婷婷六月激情综合,国产一级二级三级久久

訂購信息
上海拜力生物科技公司
Tel:400-968-7988    021-33779008
Recombinant Human IL-12 p70 (CHO derived)
品牌:PeproTech
貨號:
規(guī)格:
貨期:
應(yīng)用: 點擊這里給我發(fā)消息  咨詢客服

Recombinant Human IL-12 p70 (CHO derived)

商品詳情 參考文獻 相關(guān)資料

IL-12 is a potent regulator of cell-mediated immune responses and it induces IFN-γ production by NK and T cells.? It is produced by activated monocytes/macrophage cells, B lymphocytes and connective tissue-type mast cells.? Among its biological activities, IL-12 promotes the growth and activity of activated NK, CD4+ and CD8+ cells, and induces the development of IFN-γ-producing Th1 cells.? Recombinant Human IL-12 is a 75.0 kDa heterodimeric glycoprotein consisting of disulfide-linked 35 kDa (p35) and 40 kDa (p40) subunits (503 total amino acid residues).

Source: CHO cells

Synonyms: Interleukin-12, NKSF, CTL Maturation Factor (TCMF), Cytotoxic Lymphocyte Maturation Factor (CLMF), TSF
p35:
Interleukin-12 subunit alpha, IL-12 subunit p35, IL-12A, Cytotoxic Lymphocyte Maturation Factor 35 kDa subunit (CLMF p35), NK cell Stimulating Factor Chain 1
p40: Interleukin-12 subunit beta, IL-12 subunit p40, IL-12B, CytotoxicLymphocyte Maturation Factor 40 kDa subunit (CLMF p40), NK cell Stimulating Factor Chain 2

AA Sequence:

p35 Subunit: RNLPVATPDP GMFPCLHHSQ NLLRAVSNML QKARQTLEFY PCTSEEIDHE DITKDKTSTV EACLPLELTK NESCLNSRET SFITNGSCLA SRKTSFMMAL CLSSIYEDLK MYQVEFKTMN AKLLMDPKRQ IFLDQNMLAV IDELMQALNF NSETVPQKSS LEEPDFYKTK IKLCILLHAF RIRAVTIDRV MSYLNAS

p40 Subunit: IWELKK DVYVVELDWY PDAPGEMVVL TCDTPEEDGI TWTLDQSSEV LGSGKTLTIQ VKEFGDAGQY TCHKGGEVLS HSLLLLHKKE DGIWSTDILK DQKEPKNKTF LRCEAKNYSG RFTCWWLTTI STDLTFSVKS SRGSSDPQGV TCGAATLSAE RVRGDNKEYE YSVECQEDSA CPAAEESLPI EVMVDAVHKL KYENYTSSFF IRDIIKPDPP KNLQLKPLKN SRQVEVSWEY PDTWSTPHSY FSLTFCVQVQ GKSKREKKDR VFTDKTSATV ICRKNASISV RAQDRYYSSS WSEWASVPCS

Purity: ≥ 98% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Assay #1: Determined by its ability to induce IFN-γ production from NK cells co-stimulated with IL-18. The expected ED50 is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 106 units/mg.

Assay #2: Determined by its ability to increase IFN-γ production by anti-TCR mAb-stimulated PBMCs. The expected ED50 for this effect is 4.0-8.0 ng/ml.

Note:

1mg will be provided as 2x500μg.

熱銷產(chǎn)品
熱銷產(chǎn)品排行榜
  • 關(guān)于我們
  • 購物流程
  • 支付方式
  • 配送方式

請打開QQ掃碼聯(lián)系
Copyright@ 2003-2024  進口試劑采購網(wǎng)版權(quán)所有     

BIOLEAF熱搜   BIOLEAF試劑盒   BIOLEAF ELISA   BIOLEAF試劑   BIOLEAF品牌   BIOLEAF抗體   BIOLEAF耗材   BIOLEAF小儀器

sitemap   細胞庫查詢   危險品圖標

本公司網(wǎng)站所展示銷售的產(chǎn)品僅供科研!

         滬ICP備08023583號-6     
產(chǎn)品咨詢
QQ掃碼溝通
在線客服
服務(wù)電話
400-968-7988
掃碼關(guān)注
微信公眾號二維碼

滬公網(wǎng)安備 31011202007338號

芷江| 天等县| 榆树市| 新竹县| 呼和浩特市| 五原县| 麟游县| 大宁县| 汾西县| 泗洪县| 中超| 焉耆| 安徽省| 舞阳县| 西盟| 陇川县| 英吉沙县| 德安县| 竹溪县| 屏东县| 津市市| 阿拉善右旗| 泸州市| 东至县| 斗六市| 台北县| 凤山县| 耿马| 务川| 南丹县| 普安县| 山东省| 安义县| 云霄县| 尤溪县| 宜川县| 临夏市| 吕梁市| 西华县| 疏附县| 六盘水市|